Vanguard Capital Management’s Silo Pharma SILO Stock Holding History

Vanguard Capital Management’s Portfolio SILO Stock Details SILO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$74.2K	Buy	11,956 +11,208	+1,498%	+$71.7K	﹤0.01%	3903
2026 Q1	$4.04K	Buy	+748	New	+$3.86K	﹤0.01%	4041

Other funds holding SILO

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Vanguard Capital Management's SILO Position: Q2 2026 in Review

Vanguard Capital Management increased its Silo Pharma (SILO) stake by 1,498% in Q2 2026, buying an estimated $71.7K and bringing the position to 11,956 shares worth $74.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3903.

Vanguard Capital Management first reported a position in SILO in Q1 2026 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold SILO as of Q2 2026.

Vanguard Capital Management held 11,956 shares of Silo Pharma worth $74.2K as of Q2 2026.
Vanguard Capital Management bought 11,208 Silo Pharma shares in Q2 2026, an estimated $71.7K.
Silo Pharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3903 holding.
Vanguard Capital Management first reported a position in Silo Pharma in Q1 2026 and has held it in 2 quarters since.
9 funds tracked by Wall St. Rank held Silo Pharma as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.